相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials
Michael M. Ward et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
American College of Rheumatology Hybrid Analysis of Certolizumab Pegol Plus Methotrexate in Patients With Active Rheumatoid Arthritis: Data From a 52-Week Phase III Trial
R. F. van Vollenhoven et al.
ARTHRITIS CARE & RESEARCH (2011)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
A proposed revision to the ACR20:: The hybrid measure of American College of Rheumatology response
David Felson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
C. P. Chung et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
分享论文
